<VariationArchive RecordType="classified" VariationID="8520" VariationName="NC_000019.10:g.(13206442_13207898)_(13214608_13224666)del" VariationType="Deletion" Accession="VCV000008520" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-15" DateCreated="2018-05-09" MostRecentSubmission="2018-05-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="23559" VariationID="8520">
      <GeneList>
        <Gene Symbol="CACNA1A" FullName="calcium voltage-gated channel subunit alpha1 A" GeneID="773" HGNC_ID="HGNC:1388" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13206442" stop="13506479" display_start="13206442" display_stop="13506479" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13317255" stop="13617273" display_start="13317255" display_stop="13617273" Strand="-" />
          </Location>
          <OMIM>601011</OMIM>
          <Haploinsufficiency last_evaluated="2017-05-21" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CACNA1A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-05-21" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CACNA1A">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="LOC108663985" FullName="calcium voltage-gated channel subunit alpha1 A repeat instability region" GeneID="108663985" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13207859" stop="13207898" display_start="13207859" display_stop="13207898" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129391066" FullName="MPRA-validated peak3368 silencer" GeneID="129391066" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13215601" stop="13215801" display_start="13215601" display_stop="13215801" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130063715" FullName="ATAC-STARR-seq lymphoblastoid active region 14125" GeneID="130063715" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13208240" stop="13208509" display_start="13208240" display_stop="13208509" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130063716" FullName="ATAC-STARR-seq lymphoblastoid silent region 10202" GeneID="130063716" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13208510" stop="13208559" display_start="13208510" display_stop="13208559" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130063717" FullName="ATAC-STARR-seq lymphoblastoid silent region 10203" GeneID="130063717" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13208640" stop="13208829" display_start="13208640" display_stop="13208829" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130063718" FullName="ATAC-STARR-seq lymphoblastoid active region 14127" GeneID="130063718" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13215852" stop="13216221" display_start="13215852" display_stop="13216221" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NC_000019.10:g.(13206442_13207898)_(13214608_13224666)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19p13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" outerStart="13206442" innerStart="13207898" innerStop="13214608" outerStop="13224666" display_start="13206442" display_stop="13224666" variantLength="6711" Strand="-" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" outerStart="13317256" innerStart="13318712" innerStop="13325422" outerStop="13335480" display_start="13317256" display_stop="13335480" variantLength="6711" />
      </Location>
      <OtherNameList>
        <Name>18.2-KB DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.(13206442_13207898)_(13214608_13224666)del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.(13206442_13207898)_(13214608_13224666)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.(13317256_13318712)_(13325422_13335480)del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.(13317256_13318712)_(13325422_13335480)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="nssv7487157" DB="dbVar" />
        <XRef ID="nsv1197512" DB="dbVar" />
        <XRef Type="Allelic variant" ID="601011.0034" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">Deletion from gene CACNA1A including exons 39 through 47, plus flanking sequences.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000019.10:g.(13206442_13207898)_(13214608_13224666)del AND Migraine, familial hemiplegic, 1" Accession="RCV000009046" Version="9">
        <ClassifiedConditionList TraitSetID="2340">
          <ClassifiedCondition DB="MedGen" ID="C1832884">Migraine, familial hemiplegic, 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2009-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2009-11-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-05-09" MostRecentSubmission="2018-05-09">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19586927</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2340" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5542" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Migraine, familial hemiplegic 1, with progressive cerebellar ataxia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Migraine, familial hemiplegic, 1</ElementValue>
                <XRef ID="MONDO:0007714" DB="MONDO" />
                <XRef ID="MONDO:0020756" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MHP1</ElementValue>
                <XRef Type="MIM" ID="141500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FHM</ElementValue>
                <XRef Type="MIM" ID="141500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FHM1</ElementValue>
                <XRef Type="MIM" ID="141500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Familial hemiplegic migraine (FHM) falls within the category of migraine with aura. In migraine with aura (including FHM) the neurologic symptoms of aura are unequivocally localizable to the cerebral cortex or brain stem and include visual disturbance (most common), sensory loss (e.g., numbness or paresthesias of the face or an extremity), and dysphasia (difficulty with speech). FHM must include motor involvement, such as hemiparesis (weakness of an extremity). Hemiparesis occurs with at least one other symptom during FHM aura. Neurologic deficits with FHM attacks can be prolonged for hours to days and may outlast the associated migrainous headache. FHM is often earlier in onset than typical migraine, frequently beginning in the first or second decade; the frequency of attacks tends to decrease with age. Approximately 40%-50% of families with CACNA1A-FHM have cerebellar signs ranging from nystagmus to progressive, usually late-onset mild ataxia.</Attribute>
                <XRef ID="NBK1388" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2638" />
                <XRef ID="2638" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301562</ID>
                <ID Source="BookShelf">NBK1388</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2013">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_HemiplegicMigraine-enPro1031.pdf</URL>
                <CitationText>Orphanet, Hemiplegic Migraine (HM), 2013</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/cg150</URL>
                <CitationText>UK NICE Guideline CG150, Headaches in over 12s: diagnosis and management, 2021</CitationText>
              </Citation>
              <XRef ID="569" DB="Orphanet" />
              <XRef ID="C1832884" DB="MedGen" />
              <XRef ID="MONDO:0020756" DB="MONDO" />
              <XRef Type="MIM" ID="141500" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="29263" SubmissionDate="2017-09-07" DateLastUpdated="2018-05-09" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="601011.0034_MIGRAINE, FAMILIAL HEMIPLEGIC, 1" title="CACNA1A, 18.2-KB DEL_MIGRAINE, FAMILIAL HEMIPLEGIC, 1" />
        <ClinVarAccession Accession="SCV000029263" DateUpdated="2018-05-09" DateCreated="2013-04-04" Type="SCV" Version="7" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2009-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with sporadic hemiplegic migraine (FHM1; 141500), Labrum et al. (2009) identified a heterozygous 18.2-kb deletion in the CACNA1A gene, resulting in deletion of exons 39 to 47. The deletion was not detected in a panel of 180 normal control chromosomes.</Attribute>
              <Citation>
                <ID Source="PubMed">19586927</ID>
              </Citation>
              <XRef DB="OMIM" ID="141500" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CACNA1A" />
          </GeneList>
          <Name>CACNA1A, 18.2-KB DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">18.2-KB DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="601011.0034" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MIGRAINE, FAMILIAL HEMIPLEGIC, 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="29263" TraitType="Disease" MappingType="Name" MappingValue="MIGRAINE, FAMILIAL HEMIPLEGIC, 1" MappingRef="Preferred">
        <MedGen CUI="C1832884" Name="Migraine, familial hemiplegic, 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

